Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
Clinical trial NCT03401853 · TERMINATED
Trial details
- NCT number
- NCT03401853
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-23
- Primary completion
- 2023-12-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.